Skip Navigation


ToxSci Advance Access originally published online on June 2, 2006
Toxicological Sciences 2006 93(1):172-179; doi:10.1093/toxsci/kfl031
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
93/1/172    most recent
kfl031v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chung, D.
Right arrow Articles by Caruso, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, D.
Right arrow Articles by Caruso, R. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Potential Role for Oxidative Stress in 2,2'-Dichlorobiphenyl–Induced Inhibition of Uterine Contractions but not Myometrial Gap Junctions

Daesuk Chung1 and Rita Loch Caruso2

Department of Environmental Health Sciences, University of Michigan, Ann Arbor, Michigan 48109-2029

Received May 4, 2006; accepted June 1, 2006

Previously, we reported that 2,2'-dichlorobiphenyl (2,2'-DCB)–induced decreases of amplitude and synchronization of uterine contractions are dependent on MAPK-induced phosphorylation of Connexin43 (Cx43) and inhibition of myometrial gap junctions. Recent studies show that oxidative stress inhibits uterine contractions and myometrial gap junctions also. The present study examines the hypothesis that 2,2'-DCB–induced modification of uterine contraction is dependent on oxidative stress–mediated inhibition of myometrial gap junctions via activation of mitogen-activated protein kinase (MAPK) and phosphorylation of Cx43. In uterine strips treated with {alpha}-tocopherol (100µM), deferoxamine mesylate (Def, 50µM), or superoxide dismutase (SOD, 1000 U) after a 1-h exposure to 100µM 2,2'-DCB, modification of uterine contractions reversed 1 h after initiating antioxidant treatment. Treatment of uterine strips with 100µM 2,2'-DCB for 1 h lowered total SOD activity and also induced a surge of superoxide generation after 5 min of exposure. However, myometrial cells exposed in culture to 100µM 2,2'-DCB did not produce reactive oxygen species as determined by the lack of superoxide anion generation measured by the cytochrome c reduction assay, reactive species by the formazan assay, hydrogen peroxide by the 2',7'-dichlorofluorescein assay, and lipid peroxidation by the thiobarbituric acid–reactive substance assay. Furthermore, cotreatment with SOD or Def was unable to prevent 2,2'-DCB–induced phosphorylation of Cx43, activation of MAPK, and inhibition of myometrial gap junctions. Although antioxidants reversed 2,2'-DCB–induced inhibition of uterine contraction force and synchronization, the myometrial cell culture experiments failed to support oxidative stress as a mechanistic link between 2,2'-DCB–induced inhibition of myometrial gap junctions and modification of uterine contraction.

Key Words: 2,2'-dichlorobiphenyl; oxidative stress; uterine contraction; polychlorinated biphenyl; gap junctions.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.